Found: 14
Select item for more details and to access through your institution.
Real-World Efficacy and Safety of Extended-Release Methylphenidate (PRC-063) in the Treatment of ADHD in Pediatric and Adult Subjects: Results of a Phase IV Multicenter Comparison With Lisdexamfetamine Dimesylate.
- Published in:
- Journal of Attention Disorders, 2023, v. 27, n. 7, p. 743, doi. 10.1177/10870547231172767
- By:
- Publication type:
- Article
Duloxetine in Adults With ADHD: A Randomized, Placebo-Controlled Pilot Study.
- Published in:
- Journal of Attention Disorders, 2014, v. 18, n. 2, p. 169, doi. 10.1177/1087054712443157
- By:
- Publication type:
- Article
Improvement with Duloxetine in an Adult ADHD Patient.
- Published in:
- Journal of Attention Disorders, 2009, v. 13, n. 1, p. 95, doi. 10.1177/1087054708326109
- By:
- Publication type:
- Article
Psychosocial Interventions for Attention Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis by the CADDRA Guidelines Work GROUP.
- Published in:
- Brain Sciences (2076-3425), 2022, v. 12, n. 8, p. 1023, doi. 10.3390/brainsci12081023
- By:
- Publication type:
- Article
Down and High: Reflections Regarding Depression and Cannabis.
- Published in:
- Frontiers in Psychiatry, 2021, v. 12, p. N.PAG, doi. 10.3389/fpsyt.2021.625158
- By:
- Publication type:
- Article
Chiari Malformation and Attention Deficit Hyperactivity Disorder.
- Published in:
- Case Reports in Medicine, 2020, p. 1, doi. 10.1155/2020/2694956
- By:
- Publication type:
- Article
Mindfulness-based cognitive therapy vs. a health enhancement program for the treatment of late-life depression: Study protocol for a multi-site randomized controlled trial.
- Published in:
- Frontiers in Aging Neuroscience, 2022, v. 14, p. 1, doi. 10.3389/fnagi.2022.976636
- By:
- Publication type:
- Article
Mindfulness-based cognitive therapy vs. a health enhancement program for the treatment of late-life depression: Study protocol for a multi-site randomized controlled trial.
- Published in:
- Frontiers in Aging Neuroscience, 2022, v. 14, p. 01, doi. 10.3389/fnagi.2022.976636
- By:
- Publication type:
- Article
Le phénotypage digital pour une pratique clinique en santé mentale mieux informée.
- Published in:
- Sante Mentale au Quebec, 2021, v. 46, n. 1, p. 135, doi. 10.7202/1081513ar
- By:
- Publication type:
- Article
Balance Problems, Paralysis, and Angina as Clinical Markers for Severity in Major Depression.
- Published in:
- Frontiers in Psychiatry, 2020, v. 11, p. N.PAG, doi. 10.3389/fpsyt.2020.567394
- By:
- Publication type:
- Article
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) recommendations for the management of patients with bipolar disorder with mixed presentations.
- Published in:
- Bipolar Disorders, 2021, v. 23, n. 8, p. 767, doi. 10.1111/bdi.13135
- By:
- Publication type:
- Article
The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder.
- Published in:
- Canadian Journal of Psychiatry, 2023, v. 68, n. 1, p. 5, doi. 10.1177/07067437221111371
- By:
- Publication type:
- Article
The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults with Major Depressive Disorder: Recommandations Du Groupe De Travail Du Réseau Canadien Pour Les Traitements De L'humeur Et De L'anxiété (Canmat) Concernant L'utilisation De La Kétamine Racémique Chez Les Adultes Souffrant De Trouble Dépressif Majeur
- Published in:
- Canadian Journal of Psychiatry, 2021, v. 66, n. 2, p. 113, doi. 10.1177/0706743720970860
- By:
- Publication type:
- Article
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments.
- Published in:
- 2016
- By:
- Publication type:
- journal article